PD‐1 blockade enhances the effect of targeted chemotherapy on locally advanced pMMR/MSS colorectal cancer
Abstract Background Patients with DNA mismatch repair‐proficient/microsatellite stable (pMMR/MSS) colorectal cancer (CRC), which accounts for 85% of all CRC cases, display a poor respond to immune checkpoint inhibitors (i.e., anti‐PD‐1 antibodies). pMMR/MSS CRC patients with locally advanced cancers...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2024-06-01
|
| Serier: | Cancer Medicine |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/cam4.7224 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
